174 related articles for article (PubMed ID: 29200888)
1. Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals.
Wang Z; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y
Cancer Manag Res; 2017; 9():679-689. PubMed ID: 29200888
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis.
Wang Z; Peng S; Jiang N; Wang A; Liu S; Xie H; Guo L; Cai Q; Niu Y
Oncotarget; 2017 Nov; 8(60):102361-102370. PubMed ID: 29254251
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis.
Xie Y; Chen L; Ma X; Li H; Gu L; Gao Y; Fan Y; Zhang Y; Zhang X
Sci Rep; 2017 Mar; 7():44281. PubMed ID: 28287186
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma.
Wang Z; Peng S; Guo L; Xie H; Wang A; Shang Z; Niu Y
Clin Chim Acta; 2018 Nov; 486():9-17. PubMed ID: 30006290
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value and clinicopathological features of sarcomatoid differentiation in patients with renal cell carcinoma: a systematic review and meta-analysis.
Zhang L; Wu B; Zha Z; Zhao H; Feng Y
Cancer Manag Res; 2018; 10():1687-1703. PubMed ID: 29970967
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals.
Wang Z; Peng S; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y
Clin Exp Med; 2018 May; 18(2):165-175. PubMed ID: 29362922
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of Ki-67/MIB-1 in cervical cancer: a systematic review with meta-analysis.
Pan D; Wei K; Ling Y; Su S; Zhu M; Chen G
Med Sci Monit; 2015 Mar; 21():882-9. PubMed ID: 25807305
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological value of Ki-67 expression in patients with nasopharyngeal carcinoma: a meta-analysis.
Shi Z; Jiang W; Chen X; Xu M; Wang X; Zha D
Ther Adv Med Oncol; 2020; 12():1758835920951346. PubMed ID: 33014147
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases.
Pan DH; Wen DY; Luo YH; Chen G; Yang H; Chen JQ; He Y
Onco Targets Ther; 2017; 10():3261-3276. PubMed ID: 28740401
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Ki-67/MIB-1 Expression in Meningioma Patients: A Meta-Analysis.
Li J; Liang R; Song C; Xiang Y; Liu Y
Crit Rev Eukaryot Gene Expr; 2019; 29(2):141-150. PubMed ID: 31679269
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.
Luo Y; Ren F; Liu Y; Shi Z; Tan Z; Xiong H; Dang Y; Chen G
Int J Clin Exp Med; 2015; 8(7):10235-47. PubMed ID: 26379815
[TBL] [Abstract][Full Text] [Related]
13. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
Pu Z; Wang Q; Xie H; Wang G; Hao H
Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and Clinicopathological Value of Ki-67 in Melanoma: A Meta-Analysis.
Liu Q; Peng Z; Shen L; Shen L
Front Oncol; 2021; 11():737760. PubMed ID: 34568073
[TBL] [Abstract][Full Text] [Related]
15. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of albumin-to-globulin ratio in patients with renal cell carcinoma: a meta-analysis.
Mao H; Yang F
Front Oncol; 2023; 13():1210451. PubMed ID: 37538115
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Role of Ki-67/MIB-1 in Upper Urinary-Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis.
Lei Y; Li Z; Qi L; Tong S; Li B; He W; Chen M
J Endourol; 2015 Nov; 29(11):1302-8. PubMed ID: 26083161
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and Clinicopathological Significance of the Systemic Immune-Inflammation Index in Patients With Renal Cell Carcinoma: A Meta-Analysis.
Jin M; Yuan S; Yuan Y; Yi L
Front Oncol; 2021; 11():735803. PubMed ID: 34950577
[TBL] [Abstract][Full Text] [Related]
19. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
[TBL] [Abstract][Full Text] [Related]
20. Impact of p53, MIB-1 and PECAM-1 expression on the prognosis of urothelial carcinoma of the renal pelvis.
García-Tello A; Angulo JC; Andrés G; Ramón de Fata F; Sánchez-Chapado M; López JI
Actas Urol Esp; 2014 Oct; 38(8):506-14. PubMed ID: 24702909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
